Evidence map›Paper›PMID 31431177›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2019

Is cell migration a selectable trait in the natural evolution of cancer development?

Andrea Disanza, Sara Bisi, Emanuela Frittoli, Chiara Malinverno, Stefano Marchesi, Andrea Palamidessi, Abrar Rizvi, Giorgio Scita

Abstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. The forces of cancer.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea DisanzaIFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Sara BisiIFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Emanuela FrittoliIFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Chiara MalinvernoIFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Stefano MarchesiIFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Andrea PalamidessiIFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Abrar RizviIFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Giorgio ScitaIFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selective evolutionary pressure shapes the processes and genes that enable cancer survival and expansion in a tumour-suppressive environment. A distinguishing lethal feature of malignant cancer is its dissemination and seeding of metastatic foci. A key requirement for this process is the acquisition of a migratory/invasive ability. However, how the migratory phenotype is selected for during the natural evolution of cancer and what advantage, if any, it might provide to the growing malignant cells remain open issues. In this opinion piece, we discuss three possible answers to these issues. We will examine lines of evidence from mathematical modelling of cancer evolution that indicate that migration is an intrinsic selectable property of malignant cells that directly impacts on growth dynamics and cancer geometry. Second, we will argue that migratory phenotypes can emerge as an adaptive response to unfavourable growth conditions and endow cells not only with the ability to move/invade, but also with specific metastatic traits, including drug resistance, self-renewal and survival. Finally, we will discuss the possibility that migratory phenotypes are coincidental events that emerge by happenstance in the natural evolution of cancer. This article is part of a discussion meeting issue 'Forces in cancer: interdisciplinary approaches in tumour mechanobiology'.

Indexed as

Biological EvolutionSelection, GeneticCarcinogenesisCell MovementHumansNeoplasmsPhenotypecancer evolutioncell migrationcollective motilityendocytosis

Identifiers

PMID31431177
PMCPMC6627024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.